Exact Sciences (EXAS) Receivables (2014 - 2025)

Exact Sciences (EXAS) has 12 years of Receivables data on file, last reported at $298.7 million in Q4 2025.

• Receivables for Q4 2025 came in at $298.7 million, up 8.65% year-over-year; the trailing twelve-month figure through Dec 2025 was $298.7 million (up 8.65% YoY), and the FY2025 annual result was $298.7 million, up 455.12% from the prior year.
• Receivables declined to $298.7 million in Q4 2025 per EXAS's latest filing, from $337.9 million in the prior quarter.
• Over five years, Receivables peaked at $386.0 million in Q2 2025 and troughed at $57.9 million in Q1 2025.
• A 5-year average of $240.0 million and a median of $247.4 million in 2021 frame the typical range for Receivables.
• The sharpest annual moves came in 2021 and 2025: Receivables jumped 82.89% in 2021, then plunged 79.47% in 2025.
• A 5-year view of Receivables shows it stood at $216.6 million in 2021, then retreated by 27.05% to $158.0 million in 2022, then jumped by 55.23% to $245.3 million in 2023, then gained by 12.04% to $274.9 million in 2024, then grew by 8.65% to $298.7 million in 2025.
• Business Quant data shows EXAS's Receivables at $298.7 million in Q4 2025, $337.9 million in Q3 2025, and $386.0 million in Q2 2025.